Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Medtronic
Merck
Dow
Moodys

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Details for Patent: 5,635,485

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,635,485
Title: Erythromycin compounds
Abstract:An erythromycin compound of Formula I or its non-toxic acid addition salt having antibiotic activity.
Inventor(s): Agouridas; Constantin (Nogent sur Maine, FR), Chantot; Jean-Francois (Nogent sur Maine, FR), Denis; Alexis (Paris, FR), D'Ambrieres; Solange G. (Paris, FR), Martret; Odile L. (Paris, FR)
Assignee: Roussel Uclaf (FR)
Application Number:08/426,067
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,635,485

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 5,635,485

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France94 05368May 03, 1994

International Family Members for US Patent 5,635,485

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 558   Start Trial
African Regional IP Organization (ARIPO) 9500744   Start Trial
Austria 172203   Start Trial
Australia 2449995   Start Trial
Australia 684027   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Moodys
Colorcon
Harvard Business School
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.